肥胖症基层合理用药指南

2021-05-28 中华医学会 中华全科医师杂志.2021.20(5):530-532.

肥胖症是指机体脂肪总含量过多和/或局部含量增多及分布异常,是由遗传和环境等因素共同作用而导致的慢性代谢性疾病。肥胖的特征包括3个方面:脂肪细胞的数量增多、体脂分布的失调以及局部脂肪沉积。

中文标题:

肥胖症基层合理用药指南

发布机构:

中华医学会

发布日期:

2021-05-28

简要介绍:

肥胖症是指机体脂肪总含量过多和/或局部含量增多及分布异常,是由遗传和环境等因素共同作用而导致的慢性代谢性疾病。肥胖的特征包括3个方面:脂肪细胞的数量增多、体脂分布的失调以及局部脂肪沉积。

下载附件:

(因为版权问题,不支持下载)

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080646, encodeId=10221080646b5, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:54:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079488, encodeId=3c2310e94882e, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Mon Dec 13 10:54:02 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057730, encodeId=212c105e73031, content=这里的指南好多!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211005/ff6a01a530e04965a54a199c63ec03ae/41772d46fba541e4b39cf3121163b343.jpg, createdBy=b3645625487, createdName=06, createdTime=Tue Oct 05 01:10:14 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010461, encodeId=354510104613c, content=好,基层工作者友好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 02:09:18 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004210, encodeId=252d1004210f8, content=资料完善, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e85560935, createdName=ms8000001606036102, createdTime=Sat Jul 31 12:08:42 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-12-16 龙珠

    学习好资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080646, encodeId=10221080646b5, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:54:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079488, encodeId=3c2310e94882e, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Mon Dec 13 10:54:02 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057730, encodeId=212c105e73031, content=这里的指南好多!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211005/ff6a01a530e04965a54a199c63ec03ae/41772d46fba541e4b39cf3121163b343.jpg, createdBy=b3645625487, createdName=06, createdTime=Tue Oct 05 01:10:14 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010461, encodeId=354510104613c, content=好,基层工作者友好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 02:09:18 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004210, encodeId=252d1004210f8, content=资料完善, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e85560935, createdName=ms8000001606036102, createdTime=Sat Jul 31 12:08:42 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-12-13 123a16c8m00暂无昵称

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080646, encodeId=10221080646b5, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:54:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079488, encodeId=3c2310e94882e, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Mon Dec 13 10:54:02 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057730, encodeId=212c105e73031, content=这里的指南好多!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211005/ff6a01a530e04965a54a199c63ec03ae/41772d46fba541e4b39cf3121163b343.jpg, createdBy=b3645625487, createdName=06, createdTime=Tue Oct 05 01:10:14 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010461, encodeId=354510104613c, content=好,基层工作者友好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 02:09:18 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004210, encodeId=252d1004210f8, content=资料完善, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e85560935, createdName=ms8000001606036102, createdTime=Sat Jul 31 12:08:42 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-10-05 06

    这里的指南好多!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1080646, encodeId=10221080646b5, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:54:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079488, encodeId=3c2310e94882e, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Mon Dec 13 10:54:02 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057730, encodeId=212c105e73031, content=这里的指南好多!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211005/ff6a01a530e04965a54a199c63ec03ae/41772d46fba541e4b39cf3121163b343.jpg, createdBy=b3645625487, createdName=06, createdTime=Tue Oct 05 01:10:14 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010461, encodeId=354510104613c, content=好,基层工作者友好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 02:09:18 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004210, encodeId=252d1004210f8, content=资料完善, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e85560935, createdName=ms8000001606036102, createdTime=Sat Jul 31 12:08:42 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-08-23 yeyekeke

    好,基层工作者友好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1080646, encodeId=10221080646b5, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:54:24 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079488, encodeId=3c2310e94882e, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Mon Dec 13 10:54:02 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057730, encodeId=212c105e73031, content=这里的指南好多!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211005/ff6a01a530e04965a54a199c63ec03ae/41772d46fba541e4b39cf3121163b343.jpg, createdBy=b3645625487, createdName=06, createdTime=Tue Oct 05 01:10:14 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010461, encodeId=354510104613c, content=好,基层工作者友好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=332a2318615, createdName=yeyekeke, createdTime=Mon Aug 23 02:09:18 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004210, encodeId=252d1004210f8, content=资料完善, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e85560935, createdName=ms8000001606036102, createdTime=Sat Jul 31 12:08:42 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-07-31 ms8000001606036102

    资料完善

    0

拓展阅读

2015 TES临床实践指南:肥胖症的药物管理

美国内分泌学会(TES,The Endocrine Society) · 2015-01-15

肥胖症基层诊疗指南(2019年)

中华医学会(CMA,Chinese Medical Association) · 2020-02-20

减重与代谢外科手术病人影像学检查临床适用性评价指南

国家卫生健康委能力建设和继续教育外科学专家委员会减重与代谢外科专业委员会 · 2021-05-01

基于临床的肥胖症多学科诊疗共识(2021年版)

中国医师协会外科医师分会 · 2021-11-30

肥胖症中医诊疗方案专家共识

广州医科大学附属中医医院 · 2022-06-24

2022 NICE指南:塞美拉肽治疗LEPR或POMC缺乏性肥胖症[HST21]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2022-07-06